In addition, blocking spleen tyrosine kinases (the shared downstream signaling molecules of Fc gamma receptor (FcγR) and TLR-4) can alleviate lupus-induced inflammation (171). The gene discussed is TLR4; the disease is systemic lupus erythematosus.